Invention Grant
- Patent Title: Sublingual apomorphine
-
Application No.: US16005105Application Date: 2018-06-11
-
Publication No.: US10420763B2Publication Date: 2019-09-24
- Inventor: Anthony John Giovinazzo , David Bruce Hedden , Marc L. De Somer , Nathan John Bryson
- Applicant: Sunovion Pharmaceuticals Inc.
- Applicant Address: US MA Marlborough
- Assignee: Sunovion Pharmaceuticals Inc.
- Current Assignee: Sunovion Pharmaceuticals Inc.
- Current Assignee Address: US MA Marlborough
- Agency: Clark & Elbing LLP
- Main IPC: A61K9/70
- IPC: A61K9/70 ; A61F13/00 ; A61K31/485 ; A61K9/00 ; A61K9/06 ; A61K9/20 ; A61K31/473 ; A61K47/02 ; A61K47/10 ; A61K47/18 ; A61P25/16 ; A61P15/10
Abstract:
Disclosed are sublingual formulations of apomorphine, and methods of treating Parkinson's disease therewith. The sublingual formulations are films or strips having a first portion comprising apomorphine particles comprising an acid addition salt of apomorphine and a second portion comprising a pH neutralizing agent.
Public/Granted literature
- US20180289699A1 SUBLINGUAL APOMORPHINE Public/Granted day:2018-10-11
Information query
